Milan, Italy

Alberto Catto


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1985-1990

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Alberto Catto

Introduction

Alberto Catto is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antihypertensive agents. With a total of 2 patents, his work has had a meaningful impact on medical science.

Latest Patents

Catto's latest patents include innovative compounds such as N-piperazinylalkanoylanilides. These compounds are designed to serve as antihypertensive agents, showcasing a complex structural formula that allows for various substitutions. Additionally, he has developed omega-[4-(2-pyridyl)-piperazino]-alkanoylanilide compounds, which are effective in treating conditions such as anaphylaxis, bronchospasm, and hypertension. These therapeutic agents highlight his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Alberto Catto has worked with prominent companies in the pharmaceutical industry, including Recordati S.a. and Recordati S.a. Chemical and Pharmaceutical Company. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Catto has collaborated with esteemed colleagues such as Dante Nardi and Gabriele Graziani. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Alberto Catto's contributions to the field of pharmaceuticals through his patents and collaborations demonstrate his dedication to improving healthcare. His innovative work continues to influence the development of effective medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…